Mark Your Calendars for July 7, 2022, with Dr. Sue Ellen Carpenter of Atlanta-based Bloom Fertility
SARASOTA, Fla., July 7, 2022
/PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO)
("INVO" or the "Company"), a commercial-stage fertility company
focused on expanding access to advanced treatment worldwide with
its INVOcell® medical device and the intravaginal
culture ("IVC") procedure it enables, today announced that Dr.
Sue Ellen Carpenter of Bloom
Fertility, an INVO Center in Atlanta, will be hosting "Get to Know
INVOcell" - a Facebook Live Event on July 7,
2022 at 7 PM ET.
INVOcell allows fertilization and early embryo development to
take place within a woman's body. It offers a personal, intimate
experience in creating a baby, shows impressive success rates, and
makes advanced infertility treatment affordable.
Event link:
https://www.facebook.com/hellobloomfertilityclinic/
Dr. Carpenter said, "After both of my children experienced
infertility, I decided that we needed to address fertility
treatment in a new way. This is why we founded Bloom Fertility and
opened an INVO Center in Atlanta.
I'm here to help. With over 30 years of experience in reproductive
medicine, my specialties include fertility evaluation, fertility
coaching, ovulation induction, intrauterine insemination,
intravaginal culture and IVF. As someone who has dedicated their
life to helping people reach their goal of parenthood, I value
educating my patients on their diagnosis and treatment options. I
look forward to navigating your journey as we develop a unique plan
that will help you reach your goal of becoming a parent."
Interested participants can join the live event on July 7, 2022 and may reach out to the Bloom
Fertility office directly to schedule a complimentary 15-minute
consultation.
Bloom Fertility
6 Concourse Parkway, Suite 250
Atlanta, GA 30328
678-597-9933
www.hellobloomfertility.com
This event follows the recent Facebook Live event hosted by Dr.
Karen Hammond of Innovative
Fertility Specialists (IFS), an INVO Center located in Birmingham, AL. A replay of that live
event can be viewed here:
https://www.facebook.com/events/759676351734148/?ref=newsfeed
Innovative Fertility Specialists contact info:
Innovative Fertility Specialists
1 Inverness Center Parkway
Birmingham, AL 35242
205.509.0700
www.ifsinvo.health
About INVO Bioscience
We are a commercial-stage fertility company dedicated to
expanding the assisted reproductive technology ("ART") marketplace
by making fertility care accessible and inclusive to people around
the world. Our primary mission is to implement new medical
technologies aimed at increasing the availability of affordable,
high-quality, patient-centered fertility care. Our flagship
product is INVOcell®, a revolutionary medical device
that allows fertilization and early embryo development to take
place in vivo within the woman's body. This treatment solution
is the world's first intravaginal culture technique for the
incubation of oocytes and sperm during fertilization and early
embryo development. This technique, designated as "IVC",
provides patients a more natural, intimate, and more affordable
experience in comparison to other ART treatments. We believe
the IVC procedure can deliver comparable results at a fraction of
the cost of traditional in vitro fertilization ("IVF") and is a
significantly more effective treatment than intrauterine
insemination ("IUI"). Our commercialization strategy is
focused on the opening of dedicated "INVO Centers" offering the
INVOcell® and IVC procedure (with three centers
in North
America now operational), in addition to continuing
to distribute and sell our technology solution into existing
fertility clinics. For more information, please
visit www.invobio.com.
Safe Harbor Statement
This release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as
amended. The Company invokes the protections of the Private
Securities Litigation Reform Act of 1995. All statements
regarding our expected future financial position, results of
operations, cash flows, financing plans, business strategies,
products and services, competitive positions, growth opportunities,
plans and objectives of management for future operations, as well
as statements that include words such as "anticipate," "if,"
"believe," "plan," "estimate," "expect," "intend," "may," "could,"
"should," "will," and other similar expressions are forward-looking
statements. All forward-looking statements involve risks,
uncertainties, and contingencies, many of which are beyond our
control, which may cause actual results, performance, or
achievements to differ materially from anticipated results,
performance, or achievements. Factors that may cause actual
results to differ materially from those in the forward-looking
statements include those set forth in our filings
at www.sec.gov. We are under no obligation to (and
expressly disclaim any such obligation to) update or alter our
forward-looking statements, whether as a result of new information,
future events or otherwise.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/invo-bioscience-announces-get-to-know-invocell---a-series-of-facebook-live-events-supporting-access-to-affordable-fertility-treatment-301582054.html
SOURCE INVO Bioscience, Inc.